Mandate

Vinge ADVISES GE Capital Real Estate IN CONNECTION WITH DISPOSAL OF 89 PROPERTIES TO Kungsleden AB (publ)

October 22, 2013

Vinge is advising GE Capital Real Estate in connection with the disposal of a portfolio of 89 commercial properties to Kungsleden AB (publ). The transaction value is approximately SEK 5.5 billion and the disposal is subject to the consent of the Swedish Competition Authority. Most of the properties are situated in Stockholm and Gothenburg. The total lettable area amounts to approximately 567 000 m2 and is mostly office space.

Vinge’s team consists of Stefan de Hevesy, Patrick Forslund, Anders Frick and Niclas Winnberg. Mattias Schömer and Odile Fallenius are providing tax advice and Fredrik Gustafsson is providing employment law advice.

Related

Vinge advises Aspo on its acquisition of Swed Handling

Vinge advises Aspo, listed on Nasdaq Helsinki, in the transaction whereby Aspo's subsidiary Telko expands its chemicals business in Sweden by acquiring Swed Handling, a leading Swedish chemical distributor, from TeRa Invest. As part of the transaction, Aspo’s subsidiary Leipurin expands its food industry business in Sweden, via the technical food ingredient distributor Kebelco, which is a subsidiary of Swed Handling. The closing of the transaction is subject to customary regulatory approvals.
April 30, 2024

Vinge advises on the sale of Vinnergi Holding AB

Vinge has advised Sobro and other shareholders in connection with the sale of Vinnergi Holding AB to Polaris, a Nordic investment firm. In connection with the transaction, the management and employees are reinvesting a significant portion to further develop the company. The Vinnergi Group conducts operations in technology consulting and software development in Sweden, with a particular focus on telecoms, energy and real estate.
April 30, 2024

Vinge has advised Pareto Securities in connection with a rights issue in Episurf Medical

Vinge has advised Pareto Securities in connection with a partially secured rights issue of units of up to approximately SEK 120 million in Episurf Medical.
April 24, 2024